|
Market Cap (5-Jun) $4,172,944 (725th) |
Close (30-Jun) $0.260 |
Volume (30-Jun) 239,872 |
Shortsold (5-Oct) 64,772 (0.03%) (542nd) |
|
52w High $0.043 |
52w Low $0.012 |
P/E 11.29 |
EPS -0.06 |
UBI released this announcement to the ASX on 4 February 2022, 15:48. The announcement is not marked as price sensitive, and is 6 page(s) in length and 25.03kb in size.
You can view all announcements from UBI and see how they appear on a price chart on the announcements page.
At the date of this announcement, UBI was 0.008% short sold according to ASIC data. It was ranked the 639th most shorted stock on the ASX. It is now ranked as the 542nd most shorted stock on the ASX with 0.030% of total shares short sold as of the latest reported data (05 October 2023).
| Other Recent Announcements from UBI | |
|---|---|
| Results of 2023 Annual General meeting | 22 May 2023, 12:14 |
| CEO's AGM address to Securityholders | 22 May 2023, 8:33 |
| Q1 2023 Results | 11 May 2023, 15:41 |
| Application for quotation of securities - UBI | 4 February 2022, 15:48 |
| December 2021 Appendix 4C and Quarterly Activity Report | 28 January 2022, 15:12 |
| UBI launch Sentia Malic Acid Test globally | 18 January 2022, 11:22 |
| UBI signs deal to commercialise SARS-CoV-2 N-Protein Test | 24 December 2021, 9:11 |
You must be logged in to post a reply.
Universal Biosensors, Inc 